European Lifestyle Disorders Therapeutics Market

Published by: Frost & Sullivan

Published: Aug. 19, 2009 - 81 Pages

Table of Contents

1. Executive Summary

Executive Summary of European Lifestyle Disorders Therapeutics Market

Overview of European Lifestyle Disorders Therapeutics Market

2. Research Methodology

Objective and Scope

Research Methodology

Objective and Scope

3. Market Overview

Introduction

Disease Overview

4. Industry Challenges

Industry Challenges of Lifestyle Disorders Therapeutics Market

Key Industry Challenges

5. Market Engineering Research for Obesity Therapeutics Market

Obesity Therapeutics Market

Overview of Obesity

Market Engineering Measurements

Market Drivers

Market Restraints

Revenue Forecasts

Competitive Structure

Brand Analysis

6. Market Engineering Research for Erectile Dysfunction Therapeutics Market

Erectile Dysfunction Therapeutics Market

Overview of Erectile Dysfunction

Current Treatments Available for Erectile Dysfunction

Market Engineering Measurements

Market Drivers

Market Restraints

Revenue Forecasts

Competitive Structure

Brand Analysis

7. Strategic Recommendations

Market Engineering Recommendations

Market Engineering Strategic Recommendations

8. Database of Key Industry Participants

Key Industry Participants

Major Participants

9. Appendix

Decision Support Database Tables

Prevalence of Cardiovascular Diseases

Coronary Heart Disease Prevalence

New Cases of Diabetes

Prevalence of Obese Population

Population with Hypertension

List of Figures

Chapter 4

Impact of top five industry challenges in the European lifestyle disorders therapeutics market from 2009 to 2015

Chapter 5

Market drivers ranked in order of impact in the European obesity therapeutics market from 2009 to 2015

Market restraints ranked in order of impact in the European obesity therapeutics market from 2009 to 2015

Revenue forecasts for the European obesity therapeutics market from 2005 to 2015

Competitive structure of the European obesity therapeutics market in 2008

Available therapeutic drugs in the European obesity therapeutics market in 2008

Pipeline drugs in development in the European obesity therapeutics market in 2008

SWOT analysis of Reductil in the European obesity therapeutics market in 2008

SWOT Analysis of Xenical in the European obesity therapeutics market in 2008

Chapter 6

Market drivers ranked in order of impact in the European erectile dysfunction therapeutics market from 2009 to 2015

Market restraints ranked in order of impact in the European erectile dysfunction therapeutics market from 2009 to 2015

Revenue forecasts for the European erectile dysfunction therapeutics market from 2005 to 2015

Competitive structure of the European erectile dysfunction therapeutics market in 2008

Available therapeutic drugs in the European erectile dysfunction therapeutics market in 2008

Pipeline drugs in development in the European erectile dysfunction therapeutics market in 2008

SWOT analysis of Viagra in the European erectile dysfunction therapeutics market in 2008

SWOT analysis of Cialis in the European erectile dysfunction therapeutics market in 2008

SWOT analysis of Levitra in the European erectile dysfunction therapeutics market in 2008

Chapter 9

Prevalence of cardiovascular diseases in million worldwide from 2002 to 2012

Coronary heart disease in '000 worldwide from 2002 to 2012

New cases of diabetes in '000 worldwide from 2002 to 2012

Prevalence of obese population in million worldwide from 2004 to 2014

Population with hypertension in million worldwide from 2002 to 2014

Abstract

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports, company profiles and country profiles from over 700 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.